Rheinmetall's Order Book Keeps Swelling, Yet the Share Price Still Has Ground to Reclaim

Rheinmetall's €80B backlog grows with new Bundeswehr contract, but shares remain 40% below highs despite strong quarterly results and defence spending tailwinds.

The defence contractor's pipeline is expanding on multiple fronts, but investors remain caught between record demand and persistent valuation concerns.

Rheinmetall has secured a Bundeswehr contract for mobile field hospitals valued at more than EUR 500 million, with the order booked as far back as July. Should optional extensions be exercised, the gross volume could climb past EUR 600 million. Production of the systems is slated to begin in the first quarter of 2027.

The medical-logistics deal adds another layer to an order backlog that already exceeds EUR 80 billion. Recent additions to that pile include a loitering-munition contract, a SAFE package with Romania worth EUR 11.371 billion, and a follow-on order for 56 Elefant 2 heavy transporters at roughly EUR 60.5 million gross — an expansion of a framework agreement originally covering up to 137 vehicles.

That breadth of activity — spanning logistics, medical infrastructure and heavy equipment — underscores how far the Düsseldorf-based group has moved beyond its traditional weapons portfolio. The diversification into areas like sanitary logistics is proving timely as Germany's military modernisation gathers pace.

A Share Price Caught Between Momentum and Distance

For shareholders, the past week has been something of a rollercoaster. Last Thursday, the stock tumbled as much as 8.5 percent despite what the company described as the best quarter in its 137-year history. Since that dip, the shares have staged a meaningful recovery, trading at EUR 1,214.00 — up 6.3 percent on the week and 23 percent higher on the month.

Still, the recovery only tells part of the story. The stock remains 40 percent below its 52-week high of EUR 2,007.00, set on 3 October, and has shed 22 percent since the start of the year. At Tuesday's session, the paper was hovering around EUR 1,210.20, marginally in the red for the day.

The gap between operational momentum and share price performance reflects a broader debate about what the future holds. Analysts have largely maintained buy recommendations, pointing to structural growth drivers — now including drone-defence capabilities, which media reports suggest are moving up the group's strategic agenda as the threat from unmanned aerial vehicles intensifies.

Fiscal Tailwinds and Structural Questions

The drone-defence discussion arrives at a moment when Rheinmetall is already benefiting from Germany's wider defence-spending debate. The Institut der deutschen Wirtschaft projects a fiscal impulse of EUR 95 billion from higher defence outlays between 2026 and 2030, which its simulations suggest would generate an economic effect of EUR 96 billion.

Yet the institute also cautions that the economy has felt little of this so far. Only two percent of defence spending went into research in 2025 — a stark contrast with the 16 percent share in the United States. Financing the additional expenditure is expected to require roughly EUR 64 billion in new debt by 2029.

The macro picture is brightening, however. The ZEW economic expectations index climbed 7.9 points to 34.2 in August — a fourth consecutive monthly gain and the strongest reading since the outbreak of the Iran war. While the current-conditions barometer improved markedly, it remains deep in negative territory at minus 61.1 points. For cyclical names like Rheinmetall, a more optimistic investor outlook provides a supportive backdrop, even if defence demand is only loosely tied to the broader economy.

Signals of Confidence

Following the cancellation of the F126 frigate project in July, CEO Armin Papperger purchased Rheinmetall shares worth around EUR 3 million through his investment vehicle ATP Holding GmbH — a move widely interpreted as a vote of confidence in the group's long-term trajectory.

The steady stream of orders, from field hospitals to heavy transporters, gives investors something else: visibility. Even with individual programme setbacks, the backlog ensures that revenue expectations for the coming years rest on solid ground. The question now is whether the share price will eventually catch up with the order book — or whether the market's caution on valuation proves more durable than the flow of contracts.